Glenn G. Goddard

2018

In 2018, Glenn G. Goddard earned a total compensation of $2M as Executive Vice President, Chief Financial Officer at Intellia Therapeutics.

Compensation breakdown

Bonus$51,652
Option Awards$1,896,825
Salary$67,718
Other$218
Total$2,016,413

Goddard received $1.9M in option awards, accounting for 94% of the total pay in 2018.

Goddard also received $51.7K in bonus, $67.7K in salary and $218 in other compensation.

Rankings

In 2018, Glenn G. Goddard's compensation ranked 5,711th out of 14,244 executives tracked by ExecPay. In other words, Goddard earned more than 59.9% of executives.

ClassificationRankingPercentile
All
5,711
out of 14,244
60th
Division
Manufacturing
2,160
out of 5,765
63rd
Major group
Chemicals And Allied Products
801
out of 2,128
62nd
Industry group
Drugs
669
out of 1,817
63rd
Industry
In Vitro and In Vivo Diagnostic Substances
16
out of 72
78th
Source: SEC filing on April 16, 2019.

Goddard's colleagues

We found four more compensation records of executives who worked with Glenn G. Goddard at Intellia Therapeutics in 2018.

2018

John Leonard

Intellia Therapeutics

Chief Executive Officer

2018

Andrew Schiermeier

Intellia Therapeutics

Executive Vice President, Development and Corporate Strategy

2018

José Rivera

Intellia Therapeutics

General Counsel

2018

Graeme Bell

Intellia Therapeutics

Chief Financial Officer

News

In-depth

You may also like